Introduction

26
Bladder cancer is the ninth most frequently-diagnosed cancer worldwide [1] . In bladder clinically low-risk bladder cancer.
Materials and Methods
51
The files of 154 patients who were diagnosed with bladder cancer for the first time between 52 2009 and 2013 were retrospectively reviewed. Among them, 59 first-time patients with a 53 single lesion that was radiologically and endoscopically <3 cm in diameter were finally 54 included in the study. European Association of Urology (EAU) guidelines for non-muscle 55 invasive bladder cancer divided patients into risk groups. According to these data we consider 56 as clinically low-risk patients the ones that have the primary and solitary tumors, < 3 cm, and 57 no carcinoma in situ (CIS) characteristics [5, 7] . Patients who were diagnosed with carcinoma 58 in situ (CIS) in pathology specimens were excluded.
59
The age at first diagnosis, smoking status, stage, grade of the primary tumor, and tumor 60 diameter and number were evaluated. Patients who had no data on the records about smoking 61 habits were excluded from the study. Patients who actively smoke cigarettes or former 62 smokers were designated as ever smokers group and lifetime non-smokers were designated as 63 never smokers group. Ever smokers group consisted of 33 patients and never smokers group 64 had 26 patients. Pathological diagnoses of the patients in both groups were compared.
65
The grading of the samples was performed according to the World Health Organization The number of patients with the pathologic stage Ta was 9 (27.3%) in ever smokers group and 105 18 (69.2%) in never smokers group (p=0.003). In the never smokers group, the rate of evaluated together, the number of Ta LG patients was 11 (33.3%) and 15 (57.7%) in ever 114 smokers and never smokers groups, respectively. There were 9 Ta HG patients (27.3%) in 115 ever smokers group and zero in never smokers group. Smoking was not associated with a LG 116 pathological stage (p = 0.108) and it was found to increase the risk of Ta HG (p <0.05). The 117 number of patients with T1 HG tumors were 17 (51.5%) in ever smokers group and 2 (7.69%) 118 patients in never smokers group (p <0.05). We found that smoking was associated with a HG 
Conclusions
217
Under the light of the data, smoking seems to be associated with worse pathological features
218
(tumor stage, tumor grade) in patients with primary, single, <3cm, non-muscle-invasive 219 bladder cancer. Despite the limitations of our study, we find this finding clinically useful.
